This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2009 Feb;55(2):525.

doi: 10.1016/j.eururo.2008.11.018.

Words of wisdom. Re: Parenteral estrogen versus combined androgen deprivation in the treatment of metastatic prostatic cancer: part 2. Final evaluation of the Scandinavian Prostatic Cancer Group (SPCG) Study No. 5

Jan Adolfsson¹

Affiliations

PMID: 19606537
DOI: 10.1016/j.eururo.2008.11.018

Comment

Words of wisdom. Re: Parenteral estrogen versus combined androgen deprivation in the treatment of metastatic prostatic cancer: part 2. Final evaluation of the Scandinavian Prostatic Cancer Group (SPCG) Study No. 5

Jan Adolfsson. Eur Urol. 2009 Feb.

. 2009 Feb;55(2):525.

doi: 10.1016/j.eururo.2008.11.018.

Author

Jan Adolfsson¹

Affiliation

¹ Oncologic Center, Karolinska University Hospital, Stockholm, Sweden. jan.adolfsson@karolinska.se

PMID: 19606537
DOI: 10.1016/j.eururo.2008.11.018

No abstract available

PubMed Disclaimer

Comment on

Parenteral estrogen versus combined androgen deprivation in the treatment of metastatic prostatic cancer: part 2. Final evaluation of the Scandinavian Prostatic Cancer Group (SPCG) Study No. 5.
Hedlund PO, Damber JE, Hagerman I, Haukaas S, Henriksson P, Iversen P, Johansson R, Klarskov P, Lundbeck F, Rasmussen F, Varenhorst E, Viitanen J; SPCG-5 Study Group. Hedlund PO, et al. Scand J Urol Nephrol. 2008;42(3):220-9. doi: 10.1080/00365590801943274. Scand J Urol Nephrol. 2008. PMID: 18432528 Clinical Trial.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science